1. Volume 81, Issue 3, Pages 314-320 (February 2012)
High-dose erythropoietin has no effect on short- or long-term graft function following deceased donor kidney transplantation 
Carsten Hafer, Thomas Becker, Jan T. Kielstein, Elisabeth Bahlmann, Anke Schwarz, Nikolai Grinzoff, Daria Drzymala, Isabelle Bonnard, Nicolas Richter, Frank Lehner, Juergen Klempnauer, Hermann Haller, Jana Traeder, Danilo Fliser 
Kidney International 
Volume 81, Issue 3, Pages (February 2012)
DOI: /ki
Copyright © 2012 International Society of Nephrology Terms and Conditions

2. Figure 1
Estimated glomerular filtration rate (eGFR; based on chronic kidney disease–Epidemiology Collaboration equation) in deceased donor kidney allograft recipients randomized to recombinant human erythropoietin (rHuEPO) or placebo 6 weeks, 6 months, and 12 months after transplantation. Non-survivors were excluded from the analysis. NS, not significant.
Kidney International  , DOI: ( /ki )
Copyright © 2012 International Society of Nephrology Terms and Conditions

3. Figure 2
Mean hemoglobin levels in deceased donor kidney allograft recipients randomized to recombinant human erythropoietin (rHuEPO) or placebo during the first 6 weeks after transplantation. NS, not significant.
Kidney International  , DOI: ( /ki )
Copyright © 2012 International Society of Nephrology Terms and Conditions

4. Figure 3
CONSORT flow diagram on enrollment of patients into the study. Ninety patients undergoing deceased donor kidney transplantation were enrolled, and 88 were finally randomized to one of the two treatment arms; i.e., high-dose recombinant human erythropoietin (rHuEPO) or placebo.
Kidney International  , DOI: ( /ki )
Copyright © 2012 International Society of Nephrology Terms and Conditions